Skip to main content
CYH logo

CYH · Community Health Systems Inc

Track CYH — free
$1.62 +0.01 (+0.62%) At close · Nov 20
Market Cap
$228.46M
Shares
141.03M
Volume · Nov 20 2.93M Avg daily vol (3M) 1.65M

Price & Indicators

 

Key stats

Close
$1.62
Fri 20 Nov
Open
$1.60
Fri 20 Nov
Average volume, 30 days
2.3M
shares a session
Short interest
12.6M
8.9% of shares · 6.3 days to cover
Day range
$1.52$1.68
Open $1.60 Close $1.62
52-week closing range
$1.61$3.90
Close $1.62 58.5% under the high
Short volume, last session
66%
Last earnings
Oct 29, 2026
Latest filing
10-Q · Oct 29
Price history
Jan 2020 to Nov 2026

Up next

Feb 18, 2027 Est · unconfirmed · in 13 wks

Latest documents

2026
Nov 10
Current report 8-K Events of Nov 9
Proposed debt exchange targets $1,244 million notes

Community Health Systems, Inc. proposes exchanging any and all approximately $1,244 million of 6.875% Junior-Priority Secured Notes due 2029 for 10.250% Senior Secured Notes due 2035, alongside a consent solicitation.

Other events
2 source passages
Community Health Systems, Inc. (the “Company”) (NYSE:CYH) today announced that its wholly owned subsidiary, CHS/Community Health Systems, Inc. (the “Issuer”), intends to commence a private offer to exchange (the “Exchange Offer”) any and all of its approximately $1,244 million aggregate principal amount of outstanding 6.875% Junior-Priority Secured Notes due 2029 (the “Old Notes”) for new 10.250% Senior Secured Notes due 2035 (the “New Notes”). In addition, the Issuer intends to solicit consents (“Consents” and such solicitation, the “Consent Solicitation”) from eligible holders of the Old Notes to adopt certain proposed amendments (the “Proposed Amendments”) to the indenture governing the Old Notes (the “Old Notes Indenture”), to eliminate substantially all restrictive covenants, certain events of default and certain other provisions contained in the Old Notes Indenture. Open the document at this passage
Oct 29
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Net loss reaches $(50) million as revenue declines

Community Health Systems reported a $(50) million net loss and $2.757 billion in revenue for the three months ended September 30, 2026. Same-store revenue rose $100 million, while hospital divestitures generated approximately $1.2 billion in net proceeds.

Revenue $2.76B ▼ 10.7% Net loss $86M Diluted EPS -$0.63
Read from the MD&A section
4 source passages
we refer to Community Health Systems, Inc., or the Parent Company, and its consolidated subsidiaries We had net loss of $(50) million during the three months ended September 30, 2026, compared to net income of $171 million for the same period in 2025. Net operating revenues decreased from $3.087 billion for the three months ended September 30, 2025 to $2.757 billion for the three months ended September 30, 2026. On a same-store basis, net operating revenues for the three months ended September 30, 2026 increased $100 million compared to the same period in 2025. we received total net proceeds of approximately $1.2 billion in connection with these dispositions. Open the document at this passage
Oct 28
Current report 8-K
Third-quarter net loss of $(86) million; 2026 guidance updated

The third-quarter net loss attributable to stockholders was $(86) million, compared with net income of $130 million a year earlier, on net operating revenues of $2.757 billion, a 10.7 percent decrease. Adjusted EBITDA was $280 million, and the company updated its 2026 guidance to net operating revenues of $11,300 to $11,500 million and adjusted EBITDA of $1,225 to $1,275 million.

Financial results, Regulation FD disclosure Read from the first part of this long document
6 source passages
Net loss attributable to Community Health Systems, Inc. stockholders was $(86) million, or $(0.63) per share (diluted) compared to net income of $130 million, or $0.96 per share (diluted), for the same period in 2025 Net operating revenues for the three months ended September 30, 2026, totaled $2.757 billion, a 10.7 percent decrease Adjusted EBITDA for the three months ended September 30, 2026, was $280 million Net operating revenues (in millions) | | 11,300 | | | to | | | 11,500 | Adjusted EBITDA (in millions) | | 1,225 | | | to | | | 1,275 | Open the document at this passage
Jul 23
Quarterly report 10-Q FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $2.83B ▼ 9.8% Net income $70M ▼ 75.2% Diluted EPS $0.51 ▼ 75.6%
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$11.65B
Trailing 12 months
Net income (TTM)
$36.00M
Trailing 12 months
Revenue growth YoY
-10.7%
Year over year
Operating margin
10.9%
Trailing 12 months
P / E (TTM)
6.0
Trailing earnings · reciprocal yield 16.7%
FCF yield
-53.4%
TTM · current market cap
Return on invested capital
7.3%
Trailing 12 months
Net cash
−$9.43B
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+0.3%
Year over year · more shares
Price change (1Y)
-44.9%
Trailing year
Short interest
8.9%
Latest settlement · 6.3 days to cover
View all 125 metrics

AI Brief

Q2 FY26 earnings call · Jul 23, 2026
Q2 FY26

TL;DR. Second-quarter adjusted EBITDA fell to $330 million from $380 million, with net operating revenues down 9.8% to $2.825 billion, while same-store admissions and same-store net operating revenues grew.

Bullish
  • + Same-store admissions rose 1.9% and adjusted admissions rose 2.9% year over year.
  • + Same-store net operating revenues rose 2.4% year over year.
  • + A higher supplemental reimbursement benefit and lower contract labor and professional liability expenses partly offset the EBITDA decline.
  • + Results include benefits from recently approved Medicaid state-directed payment programs in Indiana and Florida.
  • + Twelve hospitals achieved a Leapfrog A grade, highlighting quality progress.
Bearish
  • − Net operating revenues fell 9.8% to $2.825 billion.
  • − Adjusted EBITDA fell to $330 million from $380 million, driven by divestitures, unfavorable payor mix, and higher medical specialist fees.
  • − Admissions fell 11.4% and adjusted admissions fell 11.7% on a reported basis.
  • − Net loss per diluted share excluding adjusting items widened to $(0.19) from $(0.05).
  • − Softness in elective surgery demand among commercially insured patients weighed on results.
  • − Self-pay visits rose roughly 20%.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Bearish Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 35.9 · fear Equity put/call 0.77
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −45%
below
Price vs 50-day avg −38%
below
RSI (14) 25
oversold
MACD trend Negative
52-week position 0%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −45%
trailing
6-month return −42%
trailing
YTD return −48%
this year
Relative strength −33%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $3 › 200d $3 — 200d above 50d
Institutional flow Distributing
-6% holders QoQ · +16 funds added
Insider flow Distributing
Net -$118.4K over 90 days · 100% sells
Short interest Rising
8.94% of shares out · ▲ +2.5% MoM · 6.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
172 holders — near 3-yr low, contrarian setup
Squeeze score 69
elevated · 0–100
Fundamentals
Strong
Revenue growth −1%
Y/Y
EPS growth +197%
Y/Y
Free cash flow $208.0M
Valuation P/E 6
below peers
Balance sheet $10.1B
net debt
Quant / Vol
risk profile
Very High
Volatility 56%
annualized · 1-yr
Max drawdown −59%
past year
ATR 11.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 4 of last 7
Latest guidance · from the 8-K filed Oct 28, 2026
Depreciation and amortization (percentage of net operating reven · 2026 3.8% – 3.9%
Interest expense · 2026 $820M – $830M
Net income attributable to noncontrolling interests (percentage · 2026 1.2% – 1.3%
Cash paid for interest · 2026 $800M – $810M
Provision for income taxes (percentage of net operating revenues · 2026 0.8% – 0.9%
Previous outlook earlier release · from the 8-K filed Feb 18, 2026

Still-open targets the latest release did not restate under the same label.

Net loss per share - diluted · 2026 Projection Range $-0.60 – $0.00
Guided vs delivered · last 7 settled
Net income per share - diluted Year Ending December 31, 2025
guided $0.80 – $0.90
$3.77 Beat +343.5%
Net loss per share - diluted year ending December 31, 2024
guided $-0.65 – $-0.05
$-3.90 Miss −1014.3%
Net loss per share - diluted year ending December 31, 2023
guided $-1.00 – $-0.90
$-1.02 Miss −7.4%
Net loss per share - diluted year ending December 31, 2022
guided $-2.55 – $-1.65
$0.35 Beat +116.7%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−45% Bearish
Price vs 50-day avg
−38% Bearish
RSI (14)
25 Neutral
MACD trend
Negative Bearish
52-week position
0% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross) No cross
50d $3 › 200d $3 — 200d above 50d
Institutional flow Distributing
-6% holders QoQ · +16 funds added
Insider flow Distributing
Net -$118.4K over 90 days · 100% sells
Short interest Rising
8.94% of shares out · ▲ +2.5% MoM · 6.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
172 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $2 Now $2 · 0% Range high $4
vs 200-day avg -45% vs 50-day avg -38%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted admissions percentage (decrease) increase from prior year -11.7% Three Months Ended June 30, 2026 filing —
Admissions percentage (decrease) increase from prior year -11.4% Three Months Ended June 30, 2026 filing —
Consolidated adjusted admissions change -11.7% three months ended June 30, 2026 filing —
Consolidated inpatient admissions change -11.4% three months ended June 30, 2026 filing —
Same-store adjusted admissions change non-GAAP 2.9% three months ended June 30, 2026 filing —
Same-store Admissions percentage increase from prior year 1.9% Three Months Ended June 30, 2026 filing —
Same-store inpatient admissions change non-GAAP 1.9% three months ended June 30, 2026 filing —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Medical Care Facilities — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
CYH
Community Health Systems Inc
this stock
$228.46M -48.1% -1.2% 6.0 8.9%
HCA
HCA Healthcare, Inc.
$99.34B +1.9% +7.1% 15.8 2.3%
FSNUY
Fresenius SE & Co. KGaA
$31.59B -2.2% — — 0.0%
THC
Tenet Healthcare Corp
$20.95B +32.4% +0.9% 7.6 2.2%
EHC
Encompass Health Corp
$13.11B +25.9% +10.5% 20.9 3.7%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
172
% held
79.7%
Net QoQ
-3.4M sh
Top holder
Apollo Management Holding…
Held Float
View
Held by Funds
Fund positions
148
View
Short & Settlement
Short Interest Rising
Shares short
12.6M
Days to cover
6.3d
Change
+308.3K sh
View
Short Volume
Short vol %
66%
As of
Nov 20, 2026
Short Total
View
Fails to Deliver
FTD shares
40
Value
$106
As of
Oct 29, 2026
View
Off-Exchange
Off-exchange %
42.7%
Week of
Oct 12, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$118.4K
Buyers / Sellers
0 / 1
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$12.5B
Net income (FY)
$509.0M
EPS diluted
$3.77
View
Filings
SEC Filings
Latest
8-K
Filed
Nov 10, 2026
This year
21

Community Health Systems, Inc. proposes exchanging any and all approximately $1,244 million of 6.875% Junior-Priority Secured Notes due 2029 for 10.250% Senior Secured Notes due 2035, alongside a consent solicitation.

View
Proposed Sales
Value
$120.0K
Shares
40.0K
Filed
Aug 25, 2026
View
Earnings & Events
Webcasts
Last webcast
Oct 29, 2026
View
Investor Relations
Latest news
COMMUNITY HEALTH SYSTEMS ANNOUNCE…
Published
Nov 10, 2026
View

Performance

5D 20D 120D MTD YTD
CYH -27.7% -44.5% -41.7% -32.5% -48.1%
SPY -8.6% -9.2% -9.2% -8.7% +1.2%
vs SPY -19.1% -35.3% -32.6% -23.8% -49.2%
Key facts CIK 1108109 CUSIP 203668108 13F (30d) 172 filings 156 filers Visit website Investor relations